|
|
Article: HYZAAR(R) 100-12.5 mg Offers A New Convenient Dosing Option Within The Losartan Family; New Dosage Tablet Combines the Once-Daily Efficacy of COZAAR(R) 100 mg with a Low-Dose Diuretic.
- Article from:
- Business Wire
- Article date:
- October 21, 2005
CopyrightCOPYRIGHT 2005 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
WHITEHOUSE STATION, N.J. -- Merck & Co., Inc., today announced the availability of HYZAAR(R) 100-12.5 mg (losartan potassium/hydrochlorothiazide tablets), a new tablet that combines the once-daily efficacy of 100 mg COZAAR(R) (losartan potassium tablets) with a low-dose diuretic to provide greater convenience and enhance titration options within the losartan family. HYZAAR 100-12.5 mg contains 100 mg of losartan and 12.5 mg of hydrochlorothiazide (HCTZ).
The addition of HYZAAR 100-12.5 mg to the losartan family of medicines offers a new, convenient titration step for doctors treating hypertension in patients whose blood pressure is not adequately controlled by ...